Atlas Trials

A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

Clinical trial NCT02130869 · COMPLETED

Trial details

NCT number
NCT02130869
Sponsor
St. Jude Children's Research Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
NeuroblastomaLymphomaHigh-risk Tumor
Start date
2014-10-10
Primary completion
2017-12-20
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.